MC (mesangial cell) proliferation is closely linked to the progression of glomerular disease. It has been reported that cAMP effectors suppress MC proliferation, inhibiting activation of MAPK (mitogen-activated protein kinase). In fibroblasts, activation of MAPK induces the expression of type D cyclin, whereas, in MCs, this induction has not been shown. In the present study, we explored the effects of cAMP on MAPK and expression of cell-cycle-regulated proteins. PDGF (platelet-derived growth factor) stimulated MAPK activity, up-regulated protein levels of cyclin D1, CDK2 (cyclin-dependent kinase 2) and PCNA (proliferating cell nuclear antigen), decreased the protein level of p27 and increased DNA synthesis. Fsk (forskolin) or PD98059 suppressed PDGFinduced DNA synthesis. Both agents inhibited PDGF-stimulated mRNA and protein expression of cyclin D1 and CDK2. Fsk or PD98059 also inhibited protein expression of PCNA and blocked a decrease in p27 protein. Fsk induced the phosphorylation of Raf-1 at Ser 259 , which was inhibited by KT5720. These data suggest that cAMP inhibits MC proliferation through inhibition of MAPK activity, and this mechanism partly involves alteration in the levels of cell-cycle-regulated proteins.
INTRODUCTION
MC (mesangial cell) proliferation is one of the characteristics of progressive glomerular disease. MC proliferation is affected by many factors, including growth factors. One of these, PDGF (platelet-derived growth factor), is a major potent mitogen for MCs [1] .
Previous studies performed by several groups have shown that an increase in intracellular cAMP caused by prostaglandin E2 [2] , adrenomedullin [3] , high glucose [4] or phosphodiesterase inhibitors [5] suppresses MC proliferation.
MAPK (mitogen-activated protein kinase), in particular the p42/p44 MAPK pathway, affects MC proliferation closely [6] . Multiple factors can activate MAPKs [7, 8] , especially PDGF [9, 10] in MCs. The relationship between MAPK cascade and expression of cell-cycle-regulated proteins, such as cyclins or CDKs (cyclin-dependent kinases), still remains unclear. Several studies have shown that activation of MAPK leads to cyclin D1 expression [11] [12] [13] .
D-type cyclins are involved in controlling G 1 phase progression and entry into S-phase. Increased cyclin D1 protein expression is required for MC proliferation [14] . However, some other proteins, such as CDKs, which control the cell cycle, are also required to induce mitogenesis.
In the present study, we have examined the effects of cAMP on MAPK activity and expression of cell-cycleregulated proteins in rat MCs in an attempt to investigate the critical interaction between the antimitogenic cAMP/ PKA (cAMP-dependent protein kinase) pathway, MAPK pathway and cell cycle.
Part of this work was presented at the 35th Annual Meeting of the American Society of Nephrology held in Philadelphia, PA, U.S.A., in November 2002, and subsequently published in abstract form [14a] . Kip1 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.). An antibody against PCNA (proliferating cell nuclear antigen) was obtained from DAKO (Kyoto, Japan). Fsk (forskolin) was dissolved in DMSO at a concentration of 10 mM. KT5720, a potent specific cellpermeant inhibitor of PKA, was purchased from Alexis Biochemicals (San Diego, CA, U.S.A.) and dissolved in DMSO. All other materials, including PD98059, a selective and cell-permeant inhibitor of MEK inhibitor, were purchased from Sigma (St. Louis, MO, U.S.A.) unless otherwise stated.
MATERIALS AND METHODS

Materials
MC culture
Glomerular MC preparations and primary MC cultures were prepared from rat kidneys of male SpragueDawley rats (200 g) with standard sieving methods, as reported previously [15] . Cells were grown in RPMI 1640 medium supplemented with 20 % FBS (fetal bovine serum), 100 units/ml penicillin, 100 mg/ml streptomycin, 10 µg/ml insulin, 5.5 µg/ml transferrin and 6.7 ng/ ml sodium selenite (Life Technology, Carlsbad, CA, U.S.A.). In each experiment, cells were plated at 5 × 10 5 cells in 100-mm diameter dishes (Falcon, Franklin Lakes, NJ, U.S.A.). They were made 'quiescent' by incubation for 48 h in RPMI 1640 medium in the absence of serum.
Measurement of DNA synthesis
Incorporation of the thymidine analogue BrdUrd (bromodeoxyuridine) was measured using a commercial kit for detecting BrdUrd incorporation by ELISA (Cell Proliferation ELISA BrdU calorimetric kit; Roche Diagnostics, Tokyo, Japan). Briefly, cells in RPMI 1640 and 20 % FBS were plated at 5 × 10 3 cells on 96-well plates and incubated for 72 h. After serum-starvation for 48 h in RPMI 1640, cells were incubated for 30 min in RPMI 1640 containing agents, such as Fsk, prior to stimulation with PDGF. Control cells were also incubated for 30 min with RPMI 1640 containing DMSO vehicle. The medium was then replaced with fresh medium, and the cells were stimulated with PDGF in the absence or presence of the agents for 36 h. BrdUrd (10 µM) was then added to the medium, and the cells were incubated further for 12 h within the last incubation period. The incorporation of BrdUrd was then terminated and quantified according to the manufacturer's instructions.
Determination of intracellular cAMP and protein content
cAMP was measured by enzyme immunoassay, as described previously [16] . Briefly, after serum deprivation for 24 h, cells were stimulated with medium containing Fsk. Medium was aspirated and cells were immediately immersed in 0.2 ml of 0.1 M HCl to stop the reaction. Cells were then collected into glass tubes and boiled for 3 min. After 15 min of centrifugation at 2500 g, the supernatant was decanted and 50 µl of 50 mM sodium acetate was added for the assay of cyclic nucleotides. The pellet was used for protein measurements. cAMP content of the supernatant was assayed by enzyme immunoassay (Amersham Biosciences, Tokyo, Japan).
Western blotting
Cells lysates were prepared as described previously [17] . The supernatants were then subjected to an immune complex protein kinase assay or total cell lysate immunoblotting. After incubation with the primary antibody, membranes were probed with a secondary antibody, followed by detection using ECL (enhanced chemiluminescence) Western blotting detection system (Amersham Biosciences). The intensities of the bands were quantified using a GT-9000 scanner (Epson, Tokyo, Japan), and densitometric analysis was performed using NIH Image 1.62 software. The data were obtained from three or four experiments.
Statistics
The results are expressed as means + − S.E.M. Data were analysed by ANOVA combined with Fisher's protected least-significant difference test. Differences with P < 0.05 were considered to be significant. Reading 450nm/650nm 
RESULTS
Effect of cAMP on PDGF-induced DNA synthesis
As shown in Figure 1 , addition of PDGF to the culture medium resulted in an increase in the amount of DNA synthesis. Incubation with Fsk (10 µM) and PD98059 (30 µM), a MEK inhibitor, suppressed the increase in the amount of DNA synthesis induced by PDGF. This effect of Fsk was dose-dependent ( Figure 1 ). 
Changes of intracellular cAMP content by Fsk
Effect of cAMP on MAPK pathway
We then explored the effects of Fsk and PD98059 on the p42/p44 MAPK pathway. Both agents decreased MEK phosphorylation (Figures 2A and 2F Figures 4D and 4J) proteins. However, PDGF decreased p27 protein expression, whereas Fsk blocked this suppression ( Figures 4E and 4K) . Addition of PDGF resulted in an increase in PCNA expression, which was decreased by Fsk and PD98059 ( Figures 4F  and 4L ). 
Phosphorylation of Raf-1 (Ser 259 )
We have reported previously [13] the phosphorylation of Raf-1 (Ser 259 ) by Fsk in rat VSMCs (vascular smooth muscle cells). Therefore we explored whether Fsk can induce Raf-1 phosphorylation in MCs. As shown in Figure 5 , Fsk phosphorylated Raf-1 (Ser 259 ), and this phosphorylation was inhibited by KT5720.
DISCUSSION
In the present study, we have shown that cAMP inhibits MC proliferation induced by PDGF by attenuating the MAPK cascade and modulating the expression of some cell-cycle-regulated proteins.
MAPK is an important mediator that is involved in the intracellular network of interacting proteins that transduce extracellular stimuli to intracellular responses. PDGF is a potent stimulator of MAPK in MCs, and the MAPK cascade is a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis [18, 19] . In glomeruli of rats with diabetes mellitus, a surfeit of MAPK activation has also been confirmed [20] . Although the role of the MAPK cascade in glomeruli is unclear, excessive MAPK activation in glomeruli-composed cells seems to be the main pathological trigger. It is tempting to speculate that the effect of MAPK inhibition on MC proliferation might be attributable, in part, to the inhibition of PDGF-induced intracellular signalling events in vivo.
In the present study, we have demonstrated the inhibitory effects of cAMP effectors on MC mitogenesis, consistent with previous studies reporting that the cAMP/ PKA pathway can interfere with the stimulation of MAPK pathway in MCs [3, 5, 21] . Although the precise mechanism of this inhibition is still unclear, we [13] and others [22] have reported recently the phosphorylation of Ser 259 on Raf-1 by cAMP, which is known to be a negative regulator of Raf-1 activity. Ser 259 has also been described as a target site of Raf-1 inhibition mediated by Akt/PKB (protein kinase B) [23] , although this crosstalk in MCs is obscure. It has been reported that Ser 43 and Ser 621 are target sites for PKA, which inhibit Raf-1 activity [24, 25] . Further investigations are necessary to determine the effects of cAMP on phosphorylation or dephosphorylation mechanisms of these residues. It is crucial to determine whether the PKA catalytic subunit affects phosphorylation of these residues.
One of the biological effects of MAPK is cell proliferation, but the relationship between MAPK and mitogenesis or cell division is still unclear. Upon activation in a fibroblast cell line, MAPK translocates to nucleus where it phosphorylates transcription factors and induces early gene translocation [26] . Activation of the MAPK pathway at the G 0 /G 1 transition has been shown to induce expression of cyclin D1 protein [12] . In the present study, we observed that PDGF induced cyclin D1 protein expression, which can be inhibited by both Fsk and PD98059. There are few reports investigating the effects of MAPK on other cell-cycle-regulated proteins. However, others groups have revealed that cAMP modulates expression of these factors and inhibits cell growth, especially in VSMCs [27, 28] . The cell cycle molecules induced by cAMP in MCs vary from those in VSMCs [28] . This dissociation may occur not only due to a difference in cell types, but also in culture conditions, such as variations in culture media.
In the present study, we used PD98059 as a well-known MEK inhibitor. PD98059 can inhibit both activation and phosphorylation of MEK by c-Raf. The concentration of PD98059 used in the present study (30 µM) is sufficient to block the MAPK pathway, as shown by the inhibitory effect of PD98059 on MEK phosphorylation ( Figure 2D ). PD98059 itself has no effect on the kinase activity of PKA [29] , but the possibility that PD98059 inhibits other protein kinases at the concentration used cannot be ruled out.
Recently Lin et al. [30] have shown that cAMP can suppress MC growth by inhibiting the PI3K (phosphoinositide 3-kinase)/Akt signalling pathway. It is speculated that (i) cAMP inhibits Raf-1/ERK and PI3K/Akt pathways, both of whose downstream targets are prerequisites for the induction of cell-cycle-regulating proteins, such as cyclin D1; or (ii) cAMP suppresses another pathway, other than Raf-1/ERK and PI3K/Akt, which is more critical for cell growth. Considering the data generated by many groups studying the interaction between the cAMP/PKA pathway and growth-related pathway, the former one predominates. To explore the possibility of the latter, gene chip analysis will be helpful in documenting the differences between gene expression patterns with or without cAMP effectors. In any case, comprehensive studies to examine the effect of cAMP on cell biological function will be necessary in in vitro and in vivo studies.
In vitro MCs or experimental mesangial proliferative models have shown that CDK2 and PCNA protein levels are increased and p27 protein level is decreased during the proliferative phase [14, 31, 32] . The results of the present in vitro study are in agreement with these reports. The alteration of cyclin E protein expression in a timedependent manner is consistent with the data from a previous report [33] . The difference in changes of CDK4 protein may depend on culture condition or the dose of PDGF used.
In conclusion, we have demonstrated that cAMP can suppress MC proliferation, in part, by inhibiting the MAPK cascade. This inhibition may correlate with the suppression of cell-cycle-regulated protein expression.
